Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
A crystal form and a manufacturing method for the same of a Oxazinan compound
Document Type and Number:
Japanese Patent JP5907310
Kind Code:
B2
Abstract:
Provided are: a crystal form of (-)-(2-{[3-(5-fluoropyridin-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-oxazinan-3-yl)[5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone, said crystal form being stable in the environment of usage thereof as a medicine; and a method for preparing the same. The present invention is crystals of (-)-(2-{[3-(5-fluoropyridin-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-oxazinan-3-yl)[5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone which have at least one of characteristics (a) to (c): (a) in powder X-ray diffraction (Cu-Kα), peaks appear at 2θ=11.1º, 12.5º, 20.3º and 24.2º; (b) the melting point is 124 to 129 ºC; and (c) in the infrared absorption spectrum, characteristic absorption bands appear at 1627cm-1, 1504 cm-1, 1226 cm-1, 1076 cm-1, 822 cm-1 and 783 cm-1. The present invention is also a method for preparing the crystals which is characterized by comprising: dissolving (-)-(2-{[3- (5-fluoropyridin-2-yl)-1H-pyrazol-1-yl]methyl}-1,3-oxazinan-3-yl)[5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone in a mixed solvent consisting of water and either a lower alcohol or acetone; and subjecting the solution to crystallization and then drying.

Inventors:
Nimura Aya
Noritaka Hattori
Urabe Hiroki
Ogata Yuya
Naoto Osaki
Application Number:
JP2015512427A
Publication Date:
April 26, 2016
Filing Date:
December 09, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Taisho Pharmaceutical Co., Ltd.
International Classes:
C07D413/14
Domestic Patent References:
JP2015131803A2015-07-23
JP2005501026A2005-01-13
JP2004533440A2004-11-04
JP2004534026A2004-11-11
JP2012506376A2012-03-15
Foreign References:
WO2013187467A12013-12-19
WO2013068935A12013-05-16
Attorney, Agent or Firm:
Shinjiro Ono
Yasushi Kobayashi
Shigeo Takeuchi
Osamu Yamamoto
Go Kajita